14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
JBTM vs MFP: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, JBT Marel Corporation (JBTM) is the stronger overall head-to-head candidate over MFP (MFP) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). JBTM carries a Unified Composite Score of 35.8/100 (SELL) at $120.50 (12.9x Forward P/E, 10.3% operating margin), whereas MFP carries 38.7/100 (SELL) at $44.19 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While MFP currently prints a higher short-term Unified Composite Score (38.7/100 SELL vs. JBTM 35.8/100 SELL), JBTM captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (10.3% vs. N/A operating margin) and revenue trajectory (-0.7% vs. N/A YoY).
Defensive Composite Rating Caution: Although JBTM compares more favorably head-to-head, both JBTM (35.8/100 SELL) and MFP (38.7/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on JBTM vs MFP. Trailing 12-month operating profitability (JBTM 10.3% vs MFP N/A) and valuation multiples (JBTM 12.9x vs MFP N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ JBTM vs MFP Key Questions & Quantitative Answers
As of Nov 20, 2026, JBT Marel Corporation (JBTM) is the stronger overall head-to-head candidate over MFP (MFP) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). JBTM carries a Unified Composite Score of 35.8/100 (SELL) at $120.50 (12.9x Forward P/E, 10.3% operating margin), whereas MFP carries 38.7/100 (SELL) at $44.19 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While MFP currently prints a higher short-term Unified Composite Score (38.7/100 SELL vs. JBTM 35.8/100 SELL), JBTM captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (10.3% vs. N/A operating margin) and revenue trajectory (-0.7% vs. N/A YoY). Defensive Composite Rating Caution: Although JBTM compares more favorably head-to-head, both JBTM (35.8/100 SELL) and MFP (38.7/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
JBTM leads the Growth & Scale pillar: JBTM posts -0.7% YoY revenue growth and +6.3% YoY earnings growth on $3.92B TTM revenue (35.5% gross margin, 10.3% operating margin), compared with MFP at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, JBTM generates $3.92B in USD-normalized revenue versus N/A for MFP. In operating R&D and SG&A reinvestment, JBTM deploys 25.2% of Rev ($988M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for MFP.
JBTM screens cheaper on headline valuation multiples. JBTM trades at 12.9x Forward P/E, 32.7x Trailing P/E, 1.22x PEG, and 1.6x EV/Revenue (16.4% EBITDA margin), whereas MFP trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against JBTM (4.5% ROE) versus MFP (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, JBTM carries 36.5% implied volatility (4th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.79β · 36% Vol realized risk). By comparison, MFP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.26β · 69% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.